Policy, regulatory and economical challenges
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Presentation
- By: LEUFKENS, Hubert (UU, UIPS, Pharmacoepidemiology & Pharmacotherapy, Utrecht, Netherlands)
Hubert G. Leufkens, Utrecht Institute for Pharmaceutical Sciences (UIPS) and the Dutch Medicines Evaluation Board (MEB), The Netherlands A major goal of pharmacogenomics is to shape therapy with available and new medicines in an individualised fashion, e.g. 'tailor-made pharmacotherapy'. Knowledge about individual drug-gene interactions is.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.